BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23803187)

  • 21. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
    Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
    Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche.
    Xu Y; Deng C; Chen H; Song Y; Xu H; Song G; Wang X; Luo T; Chen W; Ma J; Zeng A; Huang S; Chen Z; Fu J; Gong M; Tai Y; Huang A; Feng H; Hu J; Zhu X; Tang Q; Lu J; Wang J
    Cancer Res; 2024 Apr; 84(7):994-1012. PubMed ID: 38295227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
    Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
    Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues.
    Meuter S; Moser B
    Cytokine; 2008 Nov; 44(2):248-55. PubMed ID: 18809336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
    Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
    Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.
    Ma JF; Liu L; Yang WJ; Zang LN; Xi YM
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1102-9. PubMed ID: 23661525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of periostin gene expression via RNA interference suppressed the proliferation, apoptosis and invasion in U2OS cells.
    Liu C; Huang SJ; Qin ZL
    Chin Med J (Engl); 2010 Dec; 123(24):3677-83. PubMed ID: 22166650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ.
    Song L; Yang J; Duan P; Xu J; Luo X; Luo F; Zhang Z; Hou T; Liu B; Zhou Q
    Arch Biochem Biophys; 2013 Jul; 535(2):128-35. PubMed ID: 23578572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Smad and its signalling cascade in osteosarcoma.
    Won KY; Kim YW; Park YK
    Pathology; 2010 Apr; 42(3):242-7. PubMed ID: 20350217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCL14 inhibits trophoblast outgrowth via a paracrine/autocrine manner during early pregnancy in mice.
    Kuang H; Chen Q; Fan X; Zhang Y; Zhang L; Peng H; Cao Y; Duan E
    J Cell Physiol; 2009 Nov; 221(2):448-57. PubMed ID: 19626669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells.
    Xu X; Wang B; Xu Y
    Int J Oncol; 2013 Nov; 43(5):1578-86. PubMed ID: 23970168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
    Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
    Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.
    Shurin GV; Ferris RL; Tourkova IL; Perez L; Lokshin A; Balkir L; Collins B; Chatta GS; Shurin MR
    J Immunol; 2005 May; 174(9):5490-8. PubMed ID: 15843547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
    Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of EPHA2-siRNA plasmid on biological behavior of human osteosarcoma cells in vitro].
    Zhang LZ; Cai XS; Qian ZK; Mei J; Ma XH; Huang HY; Huang WD
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):566-9. PubMed ID: 18210872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
    Li X; Zhao L; Meng T
    Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity.
    Cao C; Wang Z; Huang L; Bai L; Wang Y; Liang Y; Dou C; Wang L
    Sci Rep; 2016 Mar; 6():23419. PubMed ID: 26996335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma.
    Parikh A; Shin J; Faquin W; Lin DT; Tirosh I; Sunwoo JB; Puram SV
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.